Although our results indicate that specific IFN-γ and IL-2 cytokines are increased during severity, we hypothesize that their release is a consequence of a severe inflammatory scenario to avoid a fatal outcome, and could be used as a prognosis biomarker for clinical management of severe COVID-19 patients. Here, IL2 is linked to COVID-19.